Five-Year Outcomes of Treat and Extend Regimen Using Intravitreal Aflibercept Injection for Treatment-Naive Age-Related Macular Degeneratio
Not Applicable
- Conditions
- Age-Related Macular Degeneration
- Registration Number
- JPRN-UMIN000052626
- Lead Sponsor
- agoya University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 112
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who received treatment including anti-VEGF intravitreal injections prior to initiation of aflibercept intravitreal injections or who have diabetic retinopathy, myopic choroidal neovascularization, or other retinal diseases in addition to AMD
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method